SALL4高表达在食管鳞癌临床病理及预后判定中的意义

doi:10.11904/j.issn.1002-3070.2021.05.006

实用肿瘤学杂志 ›› 2021, Vol. 35 ›› Issue (5): 420-425.doi: 10.11904/j.issn.1002-3070.2021.05.006

SALL4高表达在食管鳞癌临床病理及预后判定中的意义

卢俊蓉, 王惠文, 何东风

哈尔滨医科大学附属肿瘤医院介入科(哈尔滨 150086)

收稿日期:2020-04-09 修回日期:2020-10-09 出版日期:2021-10-28 发布日期:2021-10-25
通讯作者: 何东风,E-mail:13644578588@163.com
作者简介:卢俊蓉,女,(1991-),硕士,主治医师,从事消化系统肿瘤分子诊断和治疗的研究。
基金资助:
哈尔滨市科技创新人才研究专项基金(青年后备人才)(编号:2016RQQXJ228)

Significance of high expression of SALL4 in clinicopathological and prognostic judgment of esophageal squamous cell carcinoma

LU Junrong, WANG Huiwen, HE Dongfeng

Department of Invasive Technology,Harbin Medical University Cancer Hospital,Harbin 150086,China

Received:2020-04-09 Revised:2020-10-09 Online:2021-10-28 Published:2021-10-25

摘要/Abstract

摘要： 目的分析食管鳞癌(Esophageal squamous cell carcinoma,ESCC)中SALL4的表达与临床病理及生存预后的关系,探讨SALL4在食管鳞癌诊断和治疗中的作用。方法收集2010年7月—2011年11月哈尔滨医科大学附属肿瘤医院90例食管鳞癌患者的癌组织及相应的癌旁组织,采用免疫组织化学的方法检测SALL4的表达情况,比较癌组织与癌旁组织间SALL4的表达差异,并分析其与食管鳞癌患者临床特征、总生存(Overall survival,OS)及无进展生存(Progression free survival,PFS)的关系。结果食管鳞癌组织中SALL4的表达水平明显高于癌旁组织(P＜0.05),SALL4高表达与术中肿瘤部位(P=0.038)、G分级(P=0.036)和AJCC分期(P=0.015)密切关联。生存分析及Cox风险回归分析表明,SALL4高表达组的食管鳞癌患者OS和PFS均低于SALL4低表达组(P＜0.05)。结论 SALL4高表达可以作为食管鳞癌一个独立的预后判定因子,在临床工作中,可以帮助判断食管鳞癌患者的生存预后。

关键词: 食管鳞癌, 婆罗双树样基因4, 表达分析, 免疫组化, 预后生物标记物

Abstract: Objective The aims of this study were to analyze the relationship between the expression of SALL4 in esophageal squamous cell carcinoma(ESCC)and clinicopathology and survival prognosis,and to explore the role of SALL4 in the diagnosis and treatment of esophageal squamous cell carcinoma. Methods Ninety patients with ESCC were treated in Harbin Medical University Cancer Hospital from July 2010 to November 2011.The expression of SALL4 was detected in ESCC and adjacent tissues by immunohistochemistry.Its relationship with clinical characteristics of patients with ESCC,overall survival(OS)and progression free survival(PFS)were analyzed. Results The expression of SALL4 in ESCC tissues was significantly higher than that in adjacent tissues.The high expression of SALL4 was closely related to intraoperative tumor site(P=0.038),G grade(P=0.036)and AJCC stage(P=0.015).Survival analysis and Cox risk regression analysis both showed that the OS and PFS of ESCC patients in the high expression of SALL4 group were lower than those in the low expression of SALL4 group. Conclusion The high expression of SALL4 can be used as an independent prognostic factor for ESCC.In clinical work,it can help judge the survival prognosis of patients with ESCC.

Key words: Esophageal squamous cell carcinoma, SALL4, Expressional analysis, Immunohistochemistry, Prognosis biomarkers

中图分类号:

R735.1

卢俊蓉, 王惠文, 何东风. SALL4高表达在食管鳞癌临床病理及预后判定中的意义[J]. 实用肿瘤学杂志, 2021, 35(5): 420-425.

LU Junrong, WANG Huiwen, HE Dongfeng. Significance of high expression of SALL4 in clinicopathological and prognostic judgment of esophageal squamous cell carcinoma[J]. Journal of Practical Oncology, 2021, 35(5): 420-425.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2021.05.006

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2021/V35/I5/420

参考文献

1 Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
2 Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
3 张茂祥,孙惠昕,宋冰冰.2008-2012年哈尔滨市道里区恶性肿瘤发病与死亡分析[J].实用肿瘤学杂志,2019,33(3):261-265.
4 de Celis JF,Barrio R.Regulation and function of Spalt proteins during animal development[J].Int J Dev Biol,2009,53(8-10):1385-1398.
5 Rao S,Zhen S,Roumiantsev S,et al.Differential roles of Sall4 isoforms in embryonic stem cell pluripotency[J].Mol Cell Biol,2010,30(22):5364-5380.
6 Yang J,Gao C,Chai L,et al.A novel SALL4/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells[J].PLoS One,2010,5(5):e10766.
7 Masuda S,Suzuki K,Izpisua Belmonte JC.Oncofetal gene SALL4 in aggressive hepatocellular carcinoma[J].N Engl J Med,2013,369(12):1171.
8 Yue X,Xiao L,Yang Y,et al.High cytoplasmic expression of SALL4 predicts a malignant phenotype and poor prognosis of breast invasive ductal carcinoma[J].Neoplasma,2015,62(6):980-988.
9 National Health Commission of The People's Republic of China.Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018(English version)[J].Chin J Cancer Res,2019,31(2):223-258.
10 赵楠楠,秦文,韩永焕.SOX11抑制食管癌细胞增殖和迁移的机制研究[J].实用肿瘤学杂志,2020,34(1):17-23.
11 Zhang L,Xu Z,Xu X,et al.SALL4,a novel marker for human gastric carcinogenesis and metastasis[J].Oncogene,2014,33(48):5491-5500.
12 Oikawa T,Kamiya A,Zeniya M,et al.Sal-like protein 4(SALL4),a stem cell biomarker in liver cancers[J].Hepatology,2013,57(4):1469-1483.
13 Gnemmi V,Leteurtre E,Sudour-Bonnange H et al.SALL4 is a marker of the embryonal subtype of hepatoblastoma[J].Histopathology,2013,63(3):425-428.
14 Gonzalez-Roibon N,Katz B,Chaux A,et al.Immunohistochemical expression of SALL4 in hepatocellular carcinoma,a potential pitfall in the differential diagnosis of yolk sac tumors[J].Hum Pathol,2013,44(7):1293-1299.
15 Zeng SS,Yamashita T,Kondo M,et al.The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma[J].J Hepatol,2014,60(1):127-134.
16 Forghanifard MM,Ardalan Khales S,Javdani-Mallak A,et al.Stemness state regulators SALL4 and SOX2 are involved in progression and invasiveness of esophageal squamous cell carcinoma[J].Medical Oncology,2014,31(4):922.
17 Kilic E,Tennstedt P,Hogner A,et al.The zinc-finger transcription factor SALL4 is frequently expressed in human cancers:association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus[J].Virchows Arch,2016,468(4):483-492.
18 Li J,Qi Z,Hu YP,et al.Possible biomarkers for predicting lymph node metastasis of esophageal squamous cell carcinoma:a review[J].J Int Med Res,2019,47(2):544-556.

[1]	张连齐, 李吉辰, 朴松林, 赛音乌力吉, 元冬梅, 沈禹辰. PD-L1与MTA1在口腔鳞癌中的表达与临床意义[J]. 实用肿瘤学杂志, 2020, 34(3): 220-224.
[2]	王进有, 何可, 谢栋栋, 毕良宽, 徐德祥, 于德新. FBXW10与Cyclin E在肾透明细胞癌中的表达及临床意义[J]. 实用肿瘤学杂志, 2019, 33(4): 323-327.
[3]	张云艳, 刘亚琴, 王磊, 张琳, 成海燕, 杨姗姗. RIZ1蛋白表达与宫颈鳞状细胞癌临床病理参数及放疗敏感性的相关性研究[J]. 实用肿瘤学杂志, 2017, 31(5): 405-410.
[4]	张群综述，李多杰审校. PD-1/PD-L1在食管鳞癌中的研究进展[J]. 实用肿瘤学杂志, 2017, 31(3): 250-253.
[5]	于歌, 孙佳宁, 冯晓玲. 上皮性卵巢肿瘤组织中PSMD10、Ki67的表达及其临床病理意义[J]. 实用肿瘤学杂志, 2017, 31(2): 112-116.
[6]	毛维, 陈青娟, 司小敏, 张消, 蒋成. 分泌超高血清AFP胃肝样腺癌1例并文献复习[J]. 实用肿瘤学杂志, 2017, 31(1): 39-42.
[7]	周士祥，综述，李多杰，审校. 锌离子转运体LIV-1在食管鳞癌中的研究进展[J]. 实用肿瘤学杂志, 2016, 30(6): 572-576.
[8]	王小霞, 杨明, 张艳桥. SPARC蛋白在胃癌中的表达及与胃癌预后的关系[J]. 实用肿瘤学杂志, 2015, 29(6): 501-506.
[9]	刘静蕾, 姜季, 张明岩, 王影, 尤艳, 王艳. OLC1在结直肠癌中的表达及对预后影响的研究[J]. 实用肿瘤学杂志, 2015, 29(5): 390-394.
[10]	郑国良, 郑志超, 赵岩, 张涛, 张剑军. 胃癌HER-2表达的临床意义及血管新生相关性研究[J]. 实用肿瘤学杂志, 2015, 29(5): 438-443.
[11]	车爱文, 陈淑苹, 谭旭东, 李家梁, 马红梅. 宫颈癌组织中CIP2A和HPV16-E7的表达及其临床意义分析[J]. 实用肿瘤学杂志, 2015, 29(1): 29-33.
[12]	徐睿瑞, 温荔媛, 孙国强, 孟庆威, 孙立春, 蔡莉. Caveolin-1的表达与EGFR突变在NSCLC中的相关性及其临床意义的研究[J]. 实用肿瘤学杂志, 2014, 28(6): 498-502.
[13]	孙颖,田云霄,王双海,王静,宋晓明,张小辉. C-met和COX-2在甲状腺乳头状癌中的表达及其相关性研究[J]. 实用肿瘤学杂志, 2014, 28(5): 396-400.
[14]	刘运铎,孟凡玲,徐冶,杨萌. AEG-1、DLL4在子宫内膜癌中的表达及临床病理相关性的研究[J]. 实用肿瘤学杂志, 2013, 27(3): 223-228.
[15]	林梅,夏百荣,高舒. MTDH和VEGF-C在上皮性卵巢癌组织中的表达及其临床病理特征[J]. 实用肿瘤学杂志, 2013, 27(3): 229-233.

SALL4高表达在食管鳞癌临床病理及预后判定中的意义

Significance of high expression of SALL4 in clinicopathological and prognostic judgment of esophageal squamous cell carcinoma

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价